Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    "Blastomycosis"
Show Display Options
Rank Status Study
1 Completed A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis
Conditions: HIV Infections;   Histoplasmosis;   Blastomycosis
Interventions: Drug: Itraconazole;   Drug: Amphotericin B
2 Not yet recruiting Amphotericin-B and Voriconazole for Pulmonary Blastomycosis
Condition: Blastomycosis
Interventions: Drug: amphotericin-B;   Drug: voriconazole
3 Completed Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection
Condition: Blastomycosis
4 Completed Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis
Conditions: Histoplasmosis;   Sporotrichosis;   Blastomycosis
Intervention: Drug: itraconazole
5 Completed Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis
Conditions: Histoplasmosis;   Sporotrichosis;   Blastomycosis
Intervention: Drug: fluconazole
6 Completed
Has Results
A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection
Conditions: Mycoses;   Candidiasis;   Aspergillosis;   Cryptococcosis;   Blastomycosis;   Histoplasmosis;   Neutropenia
Interventions: Drug: ITCZ Oral Solution;   Drug: ITCZ-IV

Indicates status has not been verified in more than two years